This week, we’re at #SITC2024 presenting on two of our T cell engineering and computational technologies designed?with the aim?to enhance the function of our CAR-T therapies for solid tumors. Thanks to Lina Leon and Li Wang for representing ArsenalBio! Check out our SITC abstracts here:?https://lnkd.in/eHrViu2E Society for Immunotherapy of Cancer (SITC) #SITC24
关于我们
ArsenalBiosciences, Inc., is a clinical stage programmable cell therapy company focused on the realization of solid tumor cell therapy to defeat cancer. Our discovery engine comprises precise CRISPR-enabled genome editing, integrated circuits incorporating logic gates for improved tumor targeting, and therapeutic enhancements enabling multiple pharmaceutical functions. With our programmable and computationally driven approach, we aim for enhanced and broader efficacy, increased patient safety, reduced provider costs and expanded market access. Our team is engineering living medicines to attack cancer’s inherent multi-faceted nature and bring dramatic improvements to the lives of patients.
- 网站
-
https://arsenalbio.com
Arsenal Biosciences, Inc.的外部链接
- 所属行业
- 生物技术研究
- 规模
- 201-500 人
- 总部
- South San Francisco ，CA
- 类型
- 私人持股
- 创立
- 2019
- 领域
- Biotechnology、technology、artificial intelligence、cancer、immunology、cell therapy和machine learning
地点
-
主要
获取路线
US，CA，South San Francisco ，94080
Arsenal Biosciences, Inc.员工
动态
-
Hear from our CEO Ken Drazan about Arsenal’s bright future and how?we believe?our industry-leading platform enables the discovery and development of next-generation medicines. Check out this Nasdaq Live from MarketSite video: https://bit.ly/4fhpL8X
-
ArsenalBio's Senior Scientist Suchismita Mohanty, Ph.D. will present a poster sharing our latest research on AB-2100 preclinical anti-tumor activity at the AACR Special Conference in Cancer Research, October 18-21, 2024 in Boston MA. #AACR24 #cancerresearch #thoughtleaders
-
-
Welcome Nate Hardy to Arsenal
-
We are excited to announce our $325 million #SeriesC financing.? This new investment will enable ArsenalBio's ongoing development efforts and scale our manufacturing capabilities to develop T-cell medicines.? We thank the new investors along with our existing investors for their support in helping us to achieve our goal to defeat cancer. #celltherapy #patientsfirst https://lnkd.in/dimnsnfm
-
-
At ArsenalBio, our team shares a steadfast commitment to applying the latest scientific breakthroughs with the focus to develop new and effective treatments for people with solid tumor cancers. Inspired by our family members, friends, and colleagues who have faced cancer, we remain focused on advancing cutting-edge T cell-based #cancermedicines #patientsfirst #engineeringhope
-
-
At ArsenalBio, we are driven by a shared purpose that unites our teams of experts in many scientific disciplines, clinical medicines, and good manufacturing practices. Together, we are developing a new generation of T cell-based #cancermedicines #2100 #oneteam
-
-
Welcome to our 2024 summer interns-Lordean Gustinvil Caden Chu Jared Weinstein. ArsenalBio is committed to supporting and providing opportunities to future young biotech professionals.?We look forward to their contributions and the fresh perspectives and ideas they’ll bring to the teams. #internship #handsonexperience #career
-
-
Pride month is a time to both celebrate individuality and recognize the hurdles that still exist for our #LGBTQIA+ family. ArsenalBio is committed to creating an environment where all of our? #LGBTQIA+ colleagues feel empowered to bring their authentic selves to work.?Some of our team share what #Pride2024 means to them.
-
-
Today, the @ArsenalBio team honors #Juneteenth, a holiday which serves as an enduring reminder of the never-ending journey towards equality and justice for all.
-